Navigation Links
R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
Date:9/10/2007

ctions. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Pharmasset is currently developing three product candidates. Clevudine, for the treatment of chronic HBV infection, is expected to enter Phase 3 clinical trials for registration in the Americas and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a Phase 1 clinical trial through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.

About R7128

R7128 is being developed for the treatment of chronic hepatitis C. R7128 is a prodrug of PSI-6130, which demonstrated potency in preclinical studies. PSI-6130 is a pyrimidine nucleoside analog inhibitor of HCV RNA polymerase, an enzyme that is necessary for hepatitis C viral replication. Results from an oral single ascending dose study of PSI-6130 in 24 healthy male volunteers showed that PSI-6130 was generally well tolerated with no serious adverse events in doses up to 3000 mg.

R7128 Phase 1 Study Overview

The Phase 1 clinical trial is a multiple center, observer-blinded, randomized and placebo-controlled study to investigate the pharmacokinetics, pharmacodynamics, safety, tolerability and food effect of R7128 in healthy volunteers and in patients chronically infected with HCV genotype 1. This Phase 1 study is comprised of two parts:

- Part 1 is a single ascending dose study of R7128 conducted in 46

healthy volunteers. The primary objective of Part 1 is to assess the

safety, tolerability and pharmacokinetics of R7128 following single

ascending doses under fasting conditions. The secondary objective of

P
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
4. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
5. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
6. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
7. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
8. Cipralex demonstrates superiority to duloxetine for acute treatment of depression in new study
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 ... addition of the "Global Medical Technologies Market ... Medical technology is a collective term for ... used to ensure good health. The Global Medical ... anaesthetic and respiratory technology, In vitro diagnostics technology, ...
(Date:9/12/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ... results from a health economic analysis suggesting that use ... in a significant reduction in direct medical costs and ... side effects of unnecessary treatment.  "By ... conventional measures, as demonstrated in this analysis, the Oncotype ...
Breaking Medicine Technology:FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 2Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 4Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 5
(Date:9/13/2014)... MillionaireSinglesDating.com is a millionaire dating ... niche dating services provider, which also launched the ... sugar daddy site , SugarDaddyMeet.com, and the leading ... has recently reached 2 million users milestone. , ... members include CEOs, lawyers, doctors, pro athletes, models ...
(Date:9/13/2014)... York (PRWEB) September 13, 2014 Stryker ... of the 2012 Rejuvenate and ABG II Modular-Neck Hip ... underway in New Jersey’s Bergen County Superior Court, Bernstein ... issued by the Court on September 10th, 2,097 cases ... increase of 33 filings since the Court issued its ...
(Date:9/13/2014)... Reinberg HealthDay Reporter SATURDAY, ... with Ebola who is being treated at a Nebraska medical ... Dr. Rick Sacra has been a patient in the hospital,s ... center on Sept. 5. On Friday, the hospital said ... pint of Ben & Jerry,s Chocolate Chip Cookie Dough, the ...
(Date:9/13/2014)... Fit Body Boot Camp is the fastest growing ... its reputation for intense, thirty-minute fat-burning workouts. Now Keith Stafford, ... is thrilled to announce the Opening of their fitness ... on opening a Fit Body Boot Camp location for over ... opening our doors.” , The Opening will be held at ...
(Date:9/13/2014)... 13, 2014 Top10BestSEOHosting.com is a ... compared a lot of web hosting suppliers and ... Arvixe are the best ASP.NET hosting suppliers in ... ASP.NET hosting is a very popular way for ... , The IT manager is happy to introduce ...
Breaking Medicine News(10 mins):Health News:MillionaireSinglesDating.com Reaches 2 Million Users Milestone 2Health News:Stryker Hip Lawsuit News: Rejuvenate and ABG II Hip Lawsuit Filings Near 2,100 in New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: Rejuvenate and ABG II Hip Lawsuit Filings Near 2,100 in New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:American Ebola Patient Gets Appetite Back 2Health News:American Ebola Patient Gets Appetite Back 3Health News:Nashville Fit Body Boot Camp Announces Opening of New Fitness Boot Camp 2Health News:Nashville Fit Body Boot Camp Announces Opening of New Fitness Boot Camp 3Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2
... State-of-the-art, remote monitoring and clinician notification system helps ... nursing facility patients safe and clinicians happy, ... inventor of Pulse CO-Oximetry and,Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today ... remote monitoring,and clinician notification system outside of a ...
... lens UV protection, SEATTLE, June 26 ... the fourth contact lens in the,ACUVUE(R) family of ... for,Ultraviolet Absorbing Contact Lenses from the American Optometric,Association,s ... Seattle at Optometry,s Meeting(TM), the annual meeting of ...
... announced the selection,of healthcare industry veteran Mary ... President of Business Development. An experienced leader ... Ms.,Bryngelson will focus on strategically linking the ... call center operations,compliance, and administration -- to ...
... in One of Canada,s Largest Academic Cancer Centers, ... ARAY ), a global leader in the ... l,Universite de Montreal (CHUM),has purchased a CyberKnife(R) Robotic ... in Montreal, Canada., CHUM, one of the ...
... for most wound types, PRINCETON, N.J., June ... provider of advanced wound care products,announced today that ... key,product line, MEDIHONEY(TM) Wound & Burn Dressings, this ... Leptospermum Honey packaged in a,tube, and a patented ...
... June 26 "The time is right and the,wording ... to,Life. "This bill recognizes the God-given Right to Life ... it will end the slaughter of,innocent children.", S.3111, ... co-sponsors,and is scheduled for debate in the Senate Committee ...
Cached Medicine News:Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 2Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 3Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 4Health News:First Nursing Facility Installation of Masimo Patient SafetyNet(TM) Goes Live With 'Remarkable' Results 5Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 2Health News:American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses 3Health News:ACM Adds Top Industry Executive to Its Leadership Team 2Health News:First CyberKnife System to be Installed in Canada 2Health News:First CyberKnife System to be Installed in Canada 3Health News:First CyberKnife System to be Installed in Canada 4Health News:Derma Sciences Launches Two New MEDIHONEY(TM) Formulations 2Health News:Derma Sciences Launches Two New MEDIHONEY(TM) Formulations 3
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
... external ventricular drainage set (EVD ... fluid for external ventricular drainage. ... combination with a ventricular catheter ... 3XL probe from the Aesculap ...
... Bactiseal EVD Catheter system is ... catheter for external CSF drainage ... on catheter tube surfaces. Treated ... Impregnation Process, it reduces the ...
Medicine Products: